The Transmembrane Domains of the Human Multidrug Resistance P-glycoprotein Are Sufficient to Mediate Drug Binding and Trafficking to the Cell Surface
Open Access
- 1 August 1999
- journal article
- Published by Elsevier
- Vol. 274 (35) , 24759-24765
- https://doi.org/10.1074/jbc.274.35.24759
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Mutations in the Nucleotide-Binding Sites of P-Glycoprotein That Affect Substrate Specificity Modulate Substrate-Induced Adenosine Triphosphatase ActivityBiochemistry, 1998
- Inhibition of Oxidative Cross-linking between Engineered Cysteine Residues at Positions 332 in Predicted Transmembrane Segments (TM) 6 and 975 in Predicted TM12 of Human P-glycoprotein by Drug SubstratesPublished by Elsevier ,1996
- Diagnosis and reversal of multidrug resistance in paediatric cancersEuropean Journal Of Cancer, 1996
- Mutational Analysis of the Predicted First Transmembrane Segment of Each Homologous Half of Human P-glycoprotein Suggests That They Are Symmetrically Arranged in the MembraneJournal of Biological Chemistry, 1996
- Pharmacological considerations in the modulation of multidrug resistanceEuropean Journal Of Cancer, 1996
- Transmembrane Organization of Mouse P-glycoprotein Determined by Epitope Insertion and ImmunofluorescencePublished by Elsevier ,1996
- P-glycoproteinJournal of Biological Chemistry, 1995
- Functional Dissection of P-glycoprotein Nucleotide-binding Domains in Chimeric and Mutant ProteinsPublished by Elsevier ,1995
- Mutations to Amino Acids Located in Predicted Transmembrane Segment 6 (TM6) Modulate the Activity and Substrate Specificity of Human P-glycoproteinBiochemistry, 1994
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992